| ¿µ¹® | beta human chorionic gonadotropin | ÇÑ±Û | º£Å¸ »ç¶÷À¶¸ð¼º »ý½Ä»ùÀÚ±ØÈ£¸£¸ó |
|---|---|---|---|
| ¼³¸í | Źݼ¼Æ÷¿¡¼ ¸¸µé¾îÁö´Â È£¸£¸ó. ±â´ÉÀº ÀÓ½ÅÀÇ Ãʱ⿡ Ȳü(¿ø·¡ ³ÀÚ¸¦ ½Î°í ÀÖ´ø ¼¼Æ÷µéÀÌ ¹è¶õÀÌ ÀϾ¼ ³ÀÚ°¡ ºüÁ®³ª°£ ÈÄ ÁÖ¸Ó´Ï ¸ð¾çÀ» ÀÌ·é °Í. ÀÓ½ÅÃʱ⿡ ÀÓ½ÅÀÇ À¯Áö¿¡ ÇÊ¿äÇÑ È£¸£¸óÀ» »ý¼ºÇÑ´Ù)ÀÇ À¯Áö¿¡ ±â¿©Çϰí, žÆÀÇ °íȯÁ¶Á÷¿¡¼ ³²¼ºÈ£¸£¸óÀÌ ºÐºñµÇ´Â °ÍÀ» ÃËÁø½ÃŲ´Ù. ¶Ç À̰ÍÀº ÀÓ½ÅÃʱâÀÇ ÀÓ»êºÎÀÇ ¼Òº¯¿¡¼ ¸¹Àº ¾çÀÌ °ËÃâµÇ¹Ç·Î À̰ÍÀ» ÀÌ¿ëÇØ¼ ÀÓ½ÅÀÇ ¿©ºÎ¸¦ ¼Õ½±°Ô Á¶»çÇÒ ¼ö°¡ ÀÖ´Ù. |
||
| hCT | human calcitonin; human chorionic thyrotropin |
|---|---|
| TSH | Thyrotropin(Thyroid) Stimulating Hormone = Thyrotropin |
| TSHRF | Thyrotropin(Thyroid) Stimulating Hormone Releasing Factor = Thyrotropin Releasing Fa... |
| HCS | Hajdu-Cheney syndrome; Hazard Communication Standard; health care support; hourglass contraction of ... |
| HPT | histamine provocation test; human placental thyrotropin; hyperparathyroidism; hypothalamo-pituitary-... |
| HMG/HCG | human menopausal gonadotrophin/human chorionic gonadotropin |
|---|---|
| TSH | The serum thyrotropin |
| TBII | Thyrotropin binding inhibitor immunoglobulin |
| TSHR | Thyrotropin receptor |
| TRHR | Thyrotropin-Releasing Hormone Receptor |
| gonadotropin, human chorionic | A human hormone made by chorionic cells (in the foetal part of the placenta), hCG is directed at the gonads and stimulates them. HCG becomes detectable (by immunologic means) within days of fertilization and forms the foundation of the common pregnancy tests. The level of hCG in maternal serum also enters as one component in the double and the triple screens used during pregnancy to assign risks of Down syndrome and other foetal disorders. (12 Dec 1998) |
|---|---|
| chorionic gonadotropin, beta subunit, human | The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (scan j clin lab invest suppl 1993;216:97-104) (12 Dec 1998) |
| chorionic gonadotropin, human | A human hormone made by chorionic cells (in the foetal part of the placenta), hCG is directed at the gonads and stimulates them. HCG becomes detectable (by immunologic means) within days of fertilization and forms the foundation of the common pregnancy tests. The level of hCG in maternal serum also enters as one component in the double and the triple screens used during pregnancy to assign risks of Down syndrome and other foetal disorders. (12 Dec 1998) |
| hormone, human chorionic gonadotropin | A human hormone made by chorionic cells (in the foetal part of the placenta), hcg is directed at the gonads and stimulates them. Hcg becomes detectable (by immunologic means) within days of the time of fertilization. It therefore forms the foundation of most common pregnancy tests. The level of hcg in maternal serum enters as one component in the double and the triple screens used during pregnancy to assign risks of down syndrome and other foetal disorders. (12 Dec 1998) |
| human chorionic gonadotrophin | <hormone, tumour marker> A hormone that is produced by the developing placenta and by the fertilized egg after implantation in the uterine wall. This hormone is measured in the blood to determine pregnancy. Human chorionic gonadotrophin increases in quantity through the first trimester of pregnancy and begin to taper off after 85 days. Serum human chorionic gonadotrophin testing is accurate 48 hour post conception. Urine human chorionic gonadotrophin testing is a popular method of home pregnancy determination as human chorionic gonadotrophin can be detected in urine. Acronym: HCG (18 Nov 1997) |
| human chorionic gonadotropin | A human hormone made by chorionic cells (in the foetal part of the placenta), hcg is directed at the gonads and stimulates them. Hcg becomes detectable (by immunologic means) within days of fertilization and forms the foundation of the common pregnancy tests. The level of hcg in maternal serum also enters as one component in the double and the triple screens used during pregnancy to assign risks of down syndrome and other foetal disorders. (12 Dec 1998) |
| human chorionic somatomammotropic hormone | human placental lactogen |
| human chorionic somatomammotropin | human placental lactogen |
| receptors, thyrotropin | Cell surface proteins that bind thyrotropin and trigger intracellular changes influencing the behaviour of cells. These receptors are present in the nervous system and on cells in the thyroid gland. Autoantibodies to these receptors are implicated in graves', hashimoto's, and other thyroid diseases. (12 Dec 1998) |
| receptors, thyrotropin-releasing hormone | Cell surface receptors that bind thyrotropin releasing hormone (trh) with high affinity and trigger intracellular changes which influence the behaviour of cells. Activated trh receptors in the anterior pituitary stimulate the release of thyrotropin (thyroid stimulating hormone, tsh). Trh receptors on neurons mediate neurotransmission by trh. (12 Dec 1998) |
| hormone, thyrotropin | A hormone produced by the pituitary gland (at the base of the brain) that promotes the growth of the thyroid gland (in the neck) and stimulates it. The suffix -tropin indicates an affinity for. Thyrotropin has an affinity for the thyroid. Thyrotropin is known also as thyroid stimulating hormone (tsh). (12 Dec 1998) |
| thyrotropin | <endocrinology> Polypeptide hormone (28 kD), secreted by the anterior pituitary gland, that activates cyclic AMP production in thyroid cells leading to production and release of the thyroid hormones (T4 and T3). T4 and T3 blood levels feedback on the pituitary gland and decrease thyroid stimulating hormone production when T3 and T4 levels are high. (27 Sep 1997) |
| thyrotropin-producing adenoma | <tumour> A rare pituitary adenoma usually associated with hypo-or hyperthyroidism. (05 Mar 2000) |
| thyrotropin-releasing factor | Former name for thyrotropin-releasing hormone. (05 Mar 2000) |
| thyrotropin-releasing hormone | <protein> See thyrotrophic releasing hormone. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|